Transdermal delivery of bovine milk vesicles in patients with multiple sclerosis: A novel strategy to induce MOG-specific tolerance

Recently, butyrophilin (BTN) – a protein which shares cross-reactive epitopes with myelin oligodendrocyte
glycoprotein (MOG) – has been found in milk. A high amount of milk BTN has been reported in the
outer membrane of vesicular structures known as exosome and milk fat globule membrane (MFGM).
These vesicles can act as Trojan horses, passing their BTN content through epidermis or other biologic
barriers of the body. By altering the dose schedule and route of administration, the BTN-bearing vesicles
(exosomes and MFGMs) may acquire enough potential to be used in MOG-specific immunotherapy
program. Regarding above evidence and considering immunological characteristics of skin-associated
lymphoid tissue (SALT), transdermal delivery of bovine milk vesicles, whether through topical
administration of bovine milk or by using epicutaneous administration techniques, could be considered
as an intriguing approach to induce MOG-specific tolerance in patients with multiple sclerosis